Human Embryonic Kidney Cell HEK-293 Transfection Kit

Modes of administration

Reagent exhibits at least 90% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.

Description

The human embryonic kidney cell line known as HEK293 is a staple of biological research. It was originally derived from human embryonic kidney cells back in 1973, hence the name "HEK," and "293" refers to the fact that the cells were part of the 293rd experiment in a series of attempts to transform them with adenovirus 5 DNA. Researchers employ the HEK293 cell line widely in molecular biology, genetics, and biomedical research to investigate gene expression, protein production, protein interactions, and protein purification. These cells grow rapidly, are easily cultured and maintained, and can be transfected with high efficiency, enabling researchers to examine the function of specific genes and proteins. Furthermore, HEK293 cells are often utilized to create recombinant proteins and viral vectors for gene therapy. They are also valuable in drug discovery efforts, allowing scientists to screen for potential therapeutic compounds and investigate the mechanisms of drug action. Scientists have scrutinized HEK293 cells' genetics and molecular profile in-depth, and the cells' genome has been sequenced entirely. CD BioSciences provides high-efficiency lipid-based transfection reagent kits specifically optimized for the HEK-293 cell line.